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GUEST EDITORIAL 

NEW INSIGHT INTO GENETIC DISEASE. 

THE ROLE OF TRINUCLEOTIDE REPEAT EXPANSIONS 

A. Cuschieri 
The development of genetics in the last few 
decades is replete with surprise phenomena and 
new findings. Some of these offer explanations 
for old observations which had previously been 
controversial and puzzling. One such 
phenomenon is the trinucleotide repeat 
expansion, a new type of mutation first 
discovered in 1991 . This type of mutation is 
found in a number of diseases including 
myotonic dystrophy, familial mental retardation 
(Fragile X syndrome), Huntington's disease, 
spinocerebellar ataxia type I (Machado-Joseph 
disease) and spinobulbar muscular atrophy 
(Kennedy Disease). These genetic diseases 
usually appear late in life and show the unusual 
phenomenon of anticipation in which the disease 
appears earlier and increases in severity in 
subsequent generations. Furthermore anticipation 
is sex-dependent occuITing if the transmitting 
parent is the father in Huntington's disease and 
spinocerebellar atrophy and if the transmitting 
parent is the mother in myotonic dystrophy and 
the fragile X syndrome. 
Trinucleotide repeats occuITing in the middle of a 
gene are normal and quite frequent findings. The 
most common trinucleotide repeats are (CAG)n' 
(CGG)n or (CTG)n' A mutation arises when the 
segment of repeats becomes unstable and 
expands during meiosis; the disease occurs when 
the repeat length exceeds a critical size. The 
trinucleotide repeat (CAG)n is present in the 
huntingtin gene (the gene responsible for 
Huntington's disease) on chromosome 4p; in 
normal individuals 2 to 35 repeats are present but 
individuals with Huntington's disease have 40 to 
120 repeats . l Similarly Machado-Joseph disease 
is associated with expansion of (CAG)n repeats 
in the ataxin gene on chromosome 6p from the 
normal range of 6-39 to the disease range 40-81 
repeats.2 In myotonic dystrophy the 
trinucleotides (CTG)n in the myotonin kinase 
gene may be expanded up to 1500 repeats). 4 
Anticipation 
Myotonic dystrophy is the classic example of 
anticipation. The disease usually appears in early 
adult life causing weakness of the facial and 
distal limb muscles, myotonia, cataracts, and 
other symptoms. Since the turn of the century it 
was known that myotonic dystrophy can manifest 
itself with increasing severity in successive 
generations and sometimes appears as the 
congenital type with severe respiratory and 
feeding problems and impaired psychomotor 
development. The striking feature is that 
congenital myotonic dystrophy is almost 
exclusively transmitted by an affected mother, 
whereas the paternally transmitted cases are the 
adult onset type. The expanded trinucleotides 
(CTG)n are transmitted virtually unaltered by 
affected fathers but are unstable during meiosis 
in affected women and may undergo ex pansion 
by several hundred times. A mildly affected 
mother having 50 to 100 repeats may have a 
child with congenital myotonic dystrophy and 
over 1000 repeats.s 
A similar but less marked form of anticipation is 
noted in Huntington's disease in which the 
disease usually appears between 25 and 70 years 
but occasionally starts in childhood as juvenile 
chorea. In this case anticipation occurs when the 
father is affected but is gradual, being noticeable 
over several generations. In paternal transmission 
of Huntington's disease an average expansion of 
3 CAG repeats occurs in each generation .6 
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Pre-mutations 
In Familial Mental Retardation type I (FMRl or 
the Fragile X syndrome) there is a special 
situation because the condition is X-linked. The 
trinucleotide (CGG)n in the FMRl gene on the X 
chromosome has a length of 6 to 54 repeats in 
normal individuals while affected boys, who are 
mentally retarded and have mild facial 
dysmorphic features, and normal carrier females 
have 250 - 800 repeats 7.8 . When the number of 
(CGG)n repeats is between 70 and 200 it is
- termed a pre-mutation since it is not large enough 
to cause mental retardation in boys. The pre­
mutation is transmitted by normal carrier males 
to all their daughters in whom it may expand 
during meiosis causing mental retardation in half 
of their sons. 
Heterogeneity 
At present ten diseases are known to be caused 
by trinucleotide repeat expansions 9 but the list is 
expected to grow longer. Genetic heterogeneity 
often exists in diseases which clinically appear to 
be very similar but are recognisable as distinct 
entities by genetic studies . In some cases of 
fragile X syndrome it was immediately apparent 
that the classical trinucleotide (CGG)n expansion 
at the FRAX A (FM RI) gene locus was absent. 
However, a similar (CGG)n expansion was 
identified in another locus distinct from the 
FRAX-A and known as FRAX-E 10. More than 
60 X-linked mental retardation syndromes are 
known II and it is possible that other trinucleotide 
expansions may come to light as these genes are 
further charactedsed. 
A similar situation has been discovered in some 
families with clinical features resembling 
Huntington's Disease in which the expected CAG 
expansion was lacking. This led to the 
identification of the new syndrome of 
dentatorubral-pallidoluysian atrophy (DRPLA), 
so called from the brain nuclei involved. Like 
Huntington's disease it is caused by a (CAG)n 
expansion, not in the huntingtin locus on 
chromosome 4p but in the DRPLA locus on 
chromosome 12p. There is, as expected, a 
remarkably high correlation between the size of 
the repeat and the age of onset and other clinical 
manifestations of DRPLA.12 
Genetic implications 
The implications of trinucleotide expansions as a 
cause of genetic diseases, are very far-reaching. 
Firstly this is a type of mutation which differs 
radically from the classical concept of mutations. 
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Classically a mutation is a single chance event in 
which a genetic message is altered by a change in 
the sequence of nucleotides. The mutant gene is 
subsequently transmitted without further change 
through generations. However, trinucleotide 
expansions are dynamic mutations because they 
continue to change as they are transmitted 
through generations.9 Besides, they do not alter 
the sequence of the nucleotides which constitute 
the genetic message. Indeed the trinucleotide 
repeats are often situated in the introns or non­
coding segments of the gene. 
The significance of trinucleotide repeats in the 
normal genome is still largely unknown. There 
are puzzling problems , but ones of tremendous 
importance, as to how these expansions give rise 
to such severe diseases and what causes the 
repeat segments to become unstable. Possible 
answers to the first problem ha~e begun to 
emerge. Trinucleotide expansions are known to 
be associated with excessive methylation, and 
hypermethylation in its turn may inactivate or 
alter the expression of the gene.9 . 13 Since 
methylation is a gradual process it might also 
partly explain the late onset of this class of 
genetic diseases. 
The mechanism of expansion of the gene during 
meiosis IS more difficult to explain. The 
instability of the gene is not limited to meiosis 
but may also occur during mitosis. There is 
ample evidence of variations in the size of the 
repeats III different tissues of the same 
individual. 14.15 However, the factors affecting the 
stability of trinucleotide repeats are still largely 
unknown. 
Clinical implications 
There are profound clinical and practical 
implications of direct concern to affected 
families, physicians and general practitioners . 
Direct identification of the trinucleotide 
expansions enables, not only confirmation of the 
mutation in affected individuals, but also 
presymtomatic testing of their relatives who are 
at risk of developing a late onset inherited 
disease such as Huntington's disease or 
spinocerebellar ataxia. Presymptomatic DNA 
testing must be accompanied by a well-organised 
program of genetic counselling, psychological 
preparation and support ensuring that the 
individual is aware of the possible serious 
implications of a positive result and is able to 
cope with them. For this reason predictive testing 
is not usually performed on children. Prenatal 
testing of foetuses is also possible but raises 
deeply controversial ethical issues. 
l 
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The genetic facts are of 'direct concern to 
clinicians as well as geneticists. Thus a physician 
who recognizes mild symptoms of myotonic 
dystrophy in a young woman is responsible for 
referring her for genetic testing and counselling 
regarding her high risk of having a seriously 
affected child. Similarly, the genetic diagnosis of 
familial mental retardation in a boy can-ies with it 
the obl igation of counselling the rest of his 
family particularly regarding the risk to his 
normal sisters of having a severely affected child 
and the possibility of DNA testing for the 
presence of a mutation or pre-mutation. 
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